Navigation Links
Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
Date:2/22/2010

or reported (GAAP) earnings per share does not include any estimates for potential future changes in the fair value of contingent consideration or for potential new business development transactions.  These items could have a significant impact on the actual reported diluted earnings per share in the future.  A reconciliation of GAAP to non-GAAP results is attached to this press release.

Fourth Quarter 2009 Financial Results

The fourth quarter benefitted from solid contributions across both the branded and generic components of our business.  Branded drug sales rose 11% year-over-year, reflecting strong growth by key products in pain, urology and oncology.  Revenues from our generics business grew 21%, reflecting an increase in market share for Endocet, in particular, versus the fourth quarter of 2008.  The quarter also benefited from a reduction in the company's adjusted effective tax rate, reflecting a state tax rate reduction in a key jurisdiction as well as incremental tax benefits from the company's acquisition and integration of Indevus Pharmaceuticals.  This lower adjusted effective tax rate is expected to continue into 2010 and beyond.  The company's core operations generated nearly $300 million in cash flow from operations this year, most of which was redeployed in acquiring our new platform in urology and oncology.  Our new products are performing better than anticipated, with attractive growth in SUPPRELIN® LA and a strong start to our recently launched blad
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... According to the new ... Systems- Warming & Cooling), Application (Acute & Perioperative ... Nursing & Paramedical Staff) - Global Forecasts & ... the global Temperature Management Market over the forecast ... expected to reach $2.5 Billion by 2019 at ...
(Date:9/18/2014)... --This BCC Research report discusses the medical device technologies in ... size, and opportunities for different devices and regions. It includes ... in the report focuses on technological trends in recent years ... and Japan . ... medical device technologies market. - Analyze market structure, including segments ...
(Date:9/18/2014)... FRANCISCO , Sept. 18, 2014   Fruit ... has secured an initial seed round of funding. ... investments, was led by a series of individual investors, ... investors whom participated in the initial round are; ... Valley Medical Center Urologist Stacy Childs, Rapha Family Medicine ...
Breaking Medicine Technology:Temperature Management Market Worth $2.5 Billion by 2019 2Temperature Management Market Worth $2.5 Billion by 2019 3Temperature Management Market Worth $2.5 Billion by 2019 4Medical Devices: Technologies and Global Markets 2Medical Devices: Technologies and Global Markets 3Medical Devices: Technologies and Global Markets 4Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3
(Date:9/19/2014)... Final Cut Pro X plugin and effects manufacturer, ... template for Apple's Final Cut Pro X . , ... FCPX users to create a professional themed video with ease ... Pixel Film Studios, "With 48 camera options and On-Screen controls, ... Theme." , Float features all of the tools needed ...
(Date:9/19/2014)... September 19, 2014 Yisrayl Hawkins, Pastor of ... expounding on the need to protect children. He begins by ... Michael Brown and reminds that there are many other children, ... says violence is spreading faster than cancer all over the ... “There are close to seven billion Michaels in the world ...
(Date:9/19/2014)... Angeles, California (PRWEB) September 19, 2014 There ... younger man for companionship and intimacy, and there are thousands ... with an experienced, mature woman. SeekingCougar.com now provides ... This online dating website caters to older women, and the ... an easy and convenient way for these people to meet ...
(Date:9/19/2014)... VogueQueen.com has recently unveiled a new ... more beautiful at their weddings. The new range has ... company’s new products are made for the coming autumn. ... all the global clients. , “The bridal ... ordered several items on its website. I'm very satisfied ...
(Date:9/18/2014)... Petersburg, FL (PRWEB) September 19, 2014 ... with patented ingredients made just for these issues in ... includes Matrixyl, Haloxyl and Eyeliss," says Kathy Heshelow, founder ... inflammation, improving circulation and boosting collagen, to improve the ... special eye serum for wrinkles, dark circles and ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases Float Theme for Final Cut Pro X Users 2Health News:Yisrayl Hawkins Says the Michael Brown Scenario Will Continue Without Swift Action in New Post 2Health News:Dating Site "SeekingCougar.com" Now Offering Tips for Younger Men Seeking Older Women 2Health News:VogueQueen.com’s New Line Of Cheap Wedding Dresses Aims To Attract Chic Ladies 2Health News:The Secret to Improving Under-Eye Skin: 30% Off Sale and Report on Ingredients Ends Tonight on the Face Whisperer® Advanced Eye Gel 2
... New England,s largest fertility clinics expands to 12 ... Science Center,(RSC) of New England, the seventh largest ... partnership with Lowell General Hospital with,the opening of ... North Chelmsford at 10 Research Place, Suite 250., ...
... of low-risk patients are almost always benign and do not ... patients. This finding is significant because incidental adrenal lesions ... say. , The study included 973 patients with 1,049 adrenal ... of a hormonally active adrenal mass, said Julie H. Song, ...
... for evaluation of small bowel pathologies (e.g., bleeding sources). ... time and reduced visibility by air and residual material. ... defoaming agents) have been tried to improve the quality ... has been recommended for bowel preparation for CE. , ...
... Na+/H+ exchanger (NHE1) is a transmembrane protein found in ... evacuate excessive H+ in the cytoplasm by means of ... of the upregulation of NHE-1 gene expression in human ... apoptosis of tumor cells, which is helpful for the ...
... Palmetto GBA, a,leading provider of technical and administrative services ... a retired Air Force,colonel and former executive with health ... board of directors., Shields, a resident of Isle ... for Louisville, Ky.-based Humana, where he had served as ...
... interferes with abnormal cell growth seen in pulmonary hypertension ... drug sorafenib (Nexavar) shows promise as a treatment for ... Center study. , During the study, nine patients took ... those given to cancer patients. The patients also continued ...
Cached Medicine News:Health News:Reproductive Science Center and Lowell General Hospital Announce Partnership in Infertility Treatment 2Health News:How does sodium phosphate combined with bisacodyl affect small intestine? 2Health News:Sorafenib Shows Promise for Heart-Lung Disease 2
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 20-200 Inaccuracy (%) ... Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: